Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.1900
+0.0100 (5.56%)
Apr 28, 2025, 3:52 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 85.09 million as of April 28, 2025. Its market cap has decreased by -7.32% in one year.
Market Cap
85.09M
Enterprise Value
71.11M
Revenue
16.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.19
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 85.09M, a decrease of -11.39%. That is a compound annual growth rate of -3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2025 | 85.09M | -2.56% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 117.13B |
| Pro Medicus | 22.02B |
| Cochlear | 17.31B |
| Sonic Healthcare | 12.25B |
| Telix Pharmaceuticals | 9.65B |
| Ramsay Health Care | 7.63B |
| Ansell | 4.26B |
| Mesoblast | 2.29B |